VC firms back $30m series-B for Ava
A consortium of new and existing investors has backed a $30m series-B funding round for fertility tracking device maker Ava.
The majority of the funding came from existing investors, including Swisscom Ventures, Blue Ocean Ventures, Polytech Ecosystem Ventures and Zurcher Kantonbank (ZKB).
New investors included Swiss VC firm BtoV Partners and SVC, an investment vehicle managed by Credit Suisse.
The fresh capital will be used for further product research and development.
Previous funding
Swisscom and ZKB invested in a $2.6m seed round for Ava in November 2015, and both investors returned to take part in a $9.7m round alongside Blue Ocean Ventures and Polytech Ecosystem Ventures a year later.
Company
Founded in 2014 and headquartered in Zurich and San Francisco, Ava is a medical technology company developing a bracelet that detects a woman's fertility window.
The company is also working on clinical studies with the University Hospital of Zurich to expand its algorithms for use in pregnancy recognition, pregnancy monitoring, and possible use as a non-hormonal contraceptive device.
People
Ava – Pascal Koenig (co-founder).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds









